According to China Resources Pharmaceutical Group's latest financial reports the company's current revenue (TTM ) is NZ$57.50 Billion. In 2022 the company made a revenue of NZ$57.50 Billion an increase over the revenue in the year 2021 that were of NZ$53.69 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.